Annual FCF
$3.82 M
+$77.24 M+105.20%
31 December 2023
Summary:
ADMA Biologics annual free cash flow is currently $3.82 million, with the most recent change of +$77.24 million (+105.20%) on 31 December 2023. During the last 3 years, it has risen by +$129.70 million (+103.03%). ADMA annual FCF is now at all-time high.ADMA Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
$23.93 M
-$19.35 M-44.71%
30 September 2024
Summary:
ADMA Biologics quarterly free cash flow is currently $23.93 million, with the most recent change of -$19.35 million (-44.71%) on 30 September 2024. Over the past year, it has increased by +$7.74 million (+47.81%). ADMA quarterly FCF is now -44.71% below its all-time high of $43.28 million, reached on 30 June 2024.ADMA Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
$78.82 M
+$12.70 M+19.21%
30 September 2024
Summary:
ADMA Biologics TTM free cash flow is currently $78.82 million, with the most recent change of +$12.70 million (+19.21%) on 30 September 2024. Over the past year, it has increased by +$75.00 million (+1963.92%). ADMA TTM FCF is now at all-time high.ADMA TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADMA Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +47.8% | +1963.9% |
| 3 y3 years | +103.0% | +164.4% | +162.6% |
| 5 y5 years | +104.8% | +212.6% | +198.5% |
ADMA Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +103.0% | -44.7% | +164.4% | at high | +162.6% |
| 5 y | 5 years | at high | +103.0% | -44.7% | +164.4% | at high | +158.3% |
| alltime | all time | at high | +103.0% | -44.7% | +164.4% | at high | +158.3% |
ADMA Biologics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $23.93 M(-44.7%) | $78.82 M(+19.2%) |
| June 2024 | - | $43.28 M(-1045.0%) | $66.12 M(+315.7%) |
| Mar 2024 | - | -$4.58 M(-128.3%) | $15.91 M(+316.5%) |
| Dec 2023 | $3.82 M(-105.2%) | $16.19 M(+44.2%) | $3.82 M(-116.3%) |
| Sept 2023 | - | $11.23 M(-262.0%) | -$23.50 M(-54.3%) |
| June 2023 | - | -$6.93 M(-58.4%) | -$51.39 M(-16.1%) |
| Mar 2023 | - | -$16.67 M(+49.8%) | -$61.23 M(-16.6%) |
| Dec 2022 | -$73.42 M(-41.7%) | -$11.13 M(-33.2%) | -$73.42 M(-26.2%) |
| Sept 2022 | - | -$16.67 M(-0.6%) | -$99.43 M(+0.5%) |
| June 2022 | - | -$16.77 M(-41.9%) | -$98.97 M(-16.8%) |
| Mar 2022 | - | -$28.86 M(-22.3%) | -$118.94 M(-5.5%) |
| Dec 2021 | -$125.88 M(+9.7%) | -$37.14 M(+129.2%) | -$125.88 M(+1.1%) |
| Sept 2021 | - | -$16.20 M(-55.9%) | -$124.56 M(-7.8%) |
| June 2021 | - | -$36.74 M(+2.6%) | -$135.09 M(+9.1%) |
| Mar 2021 | - | -$35.80 M(-0.0%) | -$123.81 M(+7.9%) |
| Dec 2020 | -$114.73 M(+43.4%) | -$35.82 M(+34.0%) | -$114.73 M(+14.5%) |
| Sept 2020 | - | -$26.74 M(+5.0%) | -$100.16 M(+1.1%) |
| June 2020 | - | -$25.45 M(-4.7%) | -$99.02 M(+7.2%) |
| Mar 2020 | - | -$26.72 M(+25.8%) | -$92.33 M(+15.4%) |
| Dec 2019 | -$80.01 M(+23.5%) | -$21.25 M(-17.0%) | -$80.01 M(+2.1%) |
| Sept 2019 | - | -$25.60 M(+36.5%) | -$78.37 M(+19.6%) |
| June 2019 | - | -$18.76 M(+30.3%) | -$65.54 M(+5.4%) |
| Mar 2019 | - | -$14.40 M(-26.6%) | -$62.19 M(-4.0%) |
| Dec 2018 | -$64.77 M(+62.1%) | -$19.61 M(+53.5%) | -$64.77 M(+7.0%) |
| Sept 2018 | - | -$12.77 M(-17.1%) | -$60.53 M(+4.2%) |
| June 2018 | - | -$15.41 M(-9.3%) | -$58.07 M(+12.7%) |
| Mar 2018 | - | -$16.98 M(+10.5%) | -$51.53 M(+29.0%) |
| Dec 2017 | -$39.95 M | -$15.37 M(+49.1%) | -$39.95 M(+41.6%) |
| Sept 2017 | - | -$10.31 M(+16.2%) | -$28.20 M(+24.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | - | -$8.87 M(+64.2%) | -$22.58 M(+21.7%) |
| Mar 2017 | - | -$5.40 M(+49.1%) | -$18.56 M(+1.2%) |
| Dec 2016 | -$18.34 M(+18.8%) | -$3.62 M(-22.7%) | -$18.34 M(-2.4%) |
| Sept 2016 | - | -$4.69 M(-3.2%) | -$18.79 M(+12.0%) |
| June 2016 | - | -$4.84 M(-6.6%) | -$16.79 M(+2.4%) |
| Mar 2016 | - | -$5.19 M(+27.3%) | -$16.39 M(+6.2%) |
| Dec 2015 | -$15.44 M(-9.3%) | -$4.07 M(+51.9%) | -$15.44 M(+4.1%) |
| Sept 2015 | - | -$2.68 M(-39.8%) | -$14.83 M(-7.4%) |
| June 2015 | - | -$4.45 M(+5.2%) | -$16.01 M(-0.6%) |
| Mar 2015 | - | -$4.24 M(+22.4%) | -$16.11 M(-5.4%) |
| Dec 2014 | -$17.03 M(+53.6%) | -$3.46 M(-10.4%) | -$17.03 M(+3.0%) |
| Sept 2014 | - | -$3.86 M(-15.2%) | -$16.53 M(+10.9%) |
| June 2014 | - | -$4.55 M(-11.6%) | -$14.91 M(+13.9%) |
| Mar 2014 | - | -$5.15 M(+73.8%) | -$13.10 M(+18.1%) |
| Dec 2013 | -$11.08 M(+57.8%) | -$2.97 M(+32.3%) | -$11.08 M(+11.3%) |
| Sept 2013 | - | -$2.24 M(-18.0%) | -$9.96 M(+1.2%) |
| June 2013 | - | -$2.74 M(-12.9%) | -$9.85 M(+20.6%) |
| Mar 2013 | - | -$3.14 M(+70.5%) | -$8.16 M(+16.3%) |
| Dec 2012 | -$7.02 M(>+9900.0%) | -$1.84 M(-13.4%) | -$7.02 M(+35.2%) |
| Sept 2012 | - | -$2.13 M(+102.1%) | -$5.19 M(+69.2%) |
| June 2012 | - | -$1.05 M(-47.3%) | -$3.07 M(+51.6%) |
| Mar 2012 | - | -$2.00 M(>+9900.0%) | -$2.02 M(+6739.2%) |
| Dec 2011 | - | -$12.80 K(+146.2%) | -$29.60 K(+14.7%) |
| Sept 2011 | - | -$5200.00(-32.5%) | -$25.80 K(-11.0%) |
| June 2011 | -$29.00 K(+47.2%) | -$7700.00(+97.4%) | -$29.00 K(+36.2%) |
| Mar 2011 | - | -$3900.00(-56.7%) | -$21.30 K(+22.4%) |
| Dec 2010 | - | -$9000.00(+7.1%) | -$17.40 K(+107.1%) |
| Sept 2010 | - | -$8400.00 | -$8400.00 |
| June 2010 | -$19.70 K | - | - |
FAQ
- What is ADMA Biologics annual free cash flow?
- What is the all time high annual FCF for ADMA Biologics?
- What is ADMA Biologics quarterly free cash flow?
- What is the all time high quarterly FCF for ADMA Biologics?
- What is ADMA Biologics quarterly FCF year-on-year change?
- What is ADMA Biologics TTM free cash flow?
- What is the all time high TTM FCF for ADMA Biologics?
- What is ADMA Biologics TTM FCF year-on-year change?
What is ADMA Biologics annual free cash flow?
The current annual FCF of ADMA is $3.82 M
What is the all time high annual FCF for ADMA Biologics?
ADMA Biologics all-time high annual free cash flow is $3.82 M
What is ADMA Biologics quarterly free cash flow?
The current quarterly FCF of ADMA is $23.93 M
What is the all time high quarterly FCF for ADMA Biologics?
ADMA Biologics all-time high quarterly free cash flow is $43.28 M
What is ADMA Biologics quarterly FCF year-on-year change?
Over the past year, ADMA quarterly free cash flow has changed by +$7.74 M (+47.81%)
What is ADMA Biologics TTM free cash flow?
The current TTM FCF of ADMA is $78.82 M
What is the all time high TTM FCF for ADMA Biologics?
ADMA Biologics all-time high TTM free cash flow is $78.82 M
What is ADMA Biologics TTM FCF year-on-year change?
Over the past year, ADMA TTM free cash flow has changed by +$75.00 M (+1963.92%)